Abstract
This chapter reviews the role of echocardiography in evaluation of women with chest pain. Stress echocardiography is a well-established and diagnostically reliable modality for assessment of women with chest pain and suspected myocardial ischemia due to epicardial coronary artery disease. The technique is particularly suitable in women because of the lack of radiation and applicability in individuals who are or are not able to exercise. The chapter addresses the difficult issue of chest pain in women with angiographically normal coronary arteries, including prognostic role of stress echocardiography in these women, and newer echocardiographic techniques for assessment of coronary flow reserve and detection of microvascular disease. The importance of coronary flow reserve abnormalities in women with chest pain is examined.
The chapter concludes with a discussion of the role of transthoracic echocardiography in assessment of two other important cardiac causes of chest pain in women with angiographically normal coronary arteries – hypertrophic cardiomyopathy and stress-induced cardiomyopathy. The typical echocardiographic features of both types of cardiomyopathies are reviewed. Also, the role of coronary flow reserve and myocardial contrast in clarifying the causes of ischemia in these entities is examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marwick TH, Anderson T, Williams J, Haluska B, Melin JA, Pashkow F, Thomas JD. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol. 1995;26:335–41.
Sawada SG, Ryan T, Fineberg NS, Armstrong WF, Judson WE, McHenry PL, Feigenbaum H. Exercise echocardiographic detection of coronary artery disease in women. J Am Coll Cardiol. 1989;14:1440–7.
Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26:447–56.
Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellikka PA. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol. 2002;39:625–31.
Arruda AM, Das MK, Roger VL, Klarich KW, Mahoney DW, Pellikka PA. Prognostic value of exercise echocardiography in 2,632 patients ≥65 years of age. J Am Coll Cardiol. 2001;37:1036–41.
Heupler S, Mehta R, Lobo A, Leung D, Marwick TH. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:414–20.
Geleijnse ML, Krenning BJ, Soliman OII, Nemes A, Galema TW, ten Cate FG. Dobutamine stress echocardiography for the detection of coronary artery disease in women. Am J Cardiol. 2007;99:714–7.
Lewis JF, Lang L, McGorray S, Pepine CJ, Doyle M, Edmundowicz D, Holubkov R, Pohost G, Reichek N, Rogers W, Sharaf BL, Sopko G, Bairey Merz N. Dobutamine stress echocardiography in women with chest pain pilot phase data from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). J Am Coll Cardiol. 1999;33(6):1462–8.
Geleijnse ML, Krenning BJ, van Dalen BM, Nemes A, Soliman OI, Bosch JG, Galema TW, ten Cate FJ, Boersma E. Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography. J Am Soc Echocardiogr. 2009;22:1199–208.
Dionisopoulos PN, Collins JD, Smart SC, Knickelbine TA, Sagar KB. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr. 1997;10:811–7.
Ho YL, Wu CC, Huang PJ, Lin LC, Chieng PU, Chen WJ, Chen MF, Lee YT. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J. 1998;135:655–62.
Marwick T, D’Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993;22:159–67.
Blomstrand P, Engvall J, Swahn E, Safstrom K, Thulesius O, Wranne B. Cardiovascular effects of dobutamine stress testing in women with suspected coronary artery disease. Heart. 1996;75:463–8.
Shaw LJ, Shaw RE, Bairey Merz CN, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED, on behalf of the American College of Cardiology-National Cardiovascular Data Registry Investigators. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology- National Cardiovascular Data Registry. Circulation. 2008;117:1787–810.
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson Jr TB, Fihn SD, Fraker Jr TD, Gardin JM, O’Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1999 guidelines for the management of patients with chronic stable angina). J Am Coll Cardiol. 2003;41(1):159–68.
Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health – National Heart, Lung, and Blood Institute – sponsored women’s ischemia syndrome evaluation. Circulation. 2006;114:894–904.
Von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, Smith KM, Olson MB, Johnson BD, Sopko G, Handberg E, Pepine CJ, Kerensky RA. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute – Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:722–5.
Shaw LJ, Bugiardini R, Bairey Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54:1561–75.
Buchthal SD, den Hollander JA, Bairey Merz CN, Rogers WJ, Pepine CJ, Reichek N, Sharaf BL, Reis S, Kelsey SF, Pohost GM. Abnormal myocardial phospohrus-31 nuclear resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829–35.
Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim H-W, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease. Results from the National Institutes of Health – National Heart, Lung, and Blood Institute – Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993–9.
Cortigiani L, Rigo F, Gherardi S, Galderisi M, Bovenzi F, Picano E, Sicari R. Prognostic effect of coronary flow reserve in women versus men with chest pain syndrome and normal dipyridamole stress echocardiography. Am J Cardiol. 2010;106:1703–8.
Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol. 2009;103:626–31.
Ahmari SAL, Bunch J, Modesto K, Stussy V, Dichak A, Seward JB, Pellikka PA, Chandrasekran K. Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography. Am J Cardiol. 2008;101:1694–9.
Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127–33.
Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1995;26:1699–708.
Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol. 1994;73:1105–11.
Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:480–7.
Brimacombe M, Walter D, Salberg L. Gender disparity in a large nonreferral-based cohort of hypertrophic cardiomyopathy patients. J Womens Health. 2008;17:1629–34.
Caselli S, Pelliccia A, Maron M, Santini D, Puccio D, Marcantonio A, Pandian NG, De Castro S. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Am J Cardiol. 2008;102:616–20.
Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 2001;88:53–8.
Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128–30.
Ho CY, Sweitzer NK, McDonough B, et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002;105:2992–7.
Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96:716–22.
Sun JP, Stewart WJ, Sheny X, Donnell RO, Leon AR, Felner JM, Thomas JD. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103:411–5.
Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545–57.
Cannon III RO, Schenke WH, Maron BJ, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 1987;10:53–62.
O’Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation. 1987;76:1214–23.
Shah P, Choi BG, Mazhari R. Positron emission tomography for the evaluation and treatment of cardiomyopathy. Ann N Y Acad Sci. 2011;1228:137–49.
Hanrath P, Mathey D, Montz R, et al. Myocardial thallium-201 imaging in hypertrophic obstructive cardiomyopathy. Eur Heart J. 1981;2:177–85.
Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007;115:2418–25.
Lois MA, Betocchi S, Aversa M, Lombardi R, Mranda M, Cacace A, Ciampi Q, Tocchetti CG, Guida A, Chiariello M. Dobutamine stress echocardiography in hypertrophic cardiomyopathy. Cardiology. 2003;100(2):93–100.
Okeie K, Shimizu M, Yoshio H, Ino H, Yamaguchi M, Matsuyama T, Yasuda T, Taki J, Mabuchi H. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36:856–63.
Cortigiani L, Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E. Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol. 2008;102:1718–23.
Moon J, Cho IJ, Shim CY, Ha J-W, Jang Y, Chung N, Rim S-J. Abnormal myocardial capillary density in apical hypertrophic cardiomyopathy can be assessed by myocardial contrast echocardiography. Circulation. 2010;74:2166–72.
Sato H, Tateishi H, Ushida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M, editors. Clinical aspect of myocardial injury: from ischemia to heart failure. Tokyo: Kagakuhyouronsha; 1990. p. 56–64.
Bybee KA, Prasad A, Barsness GW, et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94:343–6.
Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118:2754–62.
Sharkey SW, Lesser JR, Zenovitch AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;11:472–9.
Lee PH, Song JK, Sun BJ, Choi HO, Seo JS, Na JO, Kim DH, Song JM, Kang DH, Kim JJ, Park SW. Outcomes of patients with stress-induced cardiomyopathy diagnosed by echocardiography in a tertiary referral hospital. J Am Soc Echocardiogr. 2010;23:766–71.
Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, Schunkert H, Radke PW. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest. 2007;132:809–16.
Sanai R, Mazhari R, Zeman RK, Choi BG. Coeur douloureux: transient midventricular ballooning syndrome precipitated by trigeminal neuralgia. J Am Coll Cardiol. 2009;54:1478.
Heggemann F, Hamm K, Kaelsch T, Sueselbeck T, Papavassiliu T, Borggrefe M, Haghi D. Global and regional myocardial function quantification in takotsubo cardiomyopathy in comparison to acute anterior myocardial infarction using two-dimensional (2D) strain echocardiography. Echocardiography. 2011. doi:10.1111/j.1540-8175.2011.01430.x. Epub ahead of print.
Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50:448–52.
Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333–41.
Parodi G, Bellandi B, Del Pace S, Barchielli A, Zampini L, Velluzzi S, Carrabba N, Gensini GF, Antoniucci D, Tuscany Registry of Tako-Tsubo Cardiomyopathy. Natural history of tako-tsubo cardiomyopathy. Chest. 2011;139:887–92.
Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol. 2010;56:1840–6.
Nef HM, Möllmann H, Akashi YJ, Hamm CW. Mechanisms of stress (takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010;7:187–93.
Abdelmoneim SS, Mankad SV, Bernier M, Dhoble A, Hagen ME, Ness SA, Chandrasekaran K, Pellikka PA, Oh JK, Mulvagh SL. Microvascular function in takotsubo cardiomyopathy with contrast echocardiography: prospective evaluation and review of literature. J Am Soc Echocardiogr. 2009;22:1249–55.
Afonso L, Bachour K, Awad K, Sandidge G. Takotsubo cardiomyopathy: pathogenetic insights and myocardial perfusion kinetics using myocardial contrast echocardiography. Eur J Echocardiogr. 2008;9:849–54.
Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, Rebuzzi AG, Crea F. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or tako-tsubo syndrome. Eur Heart J. 2010;31:1319–27.
Meimoun P, Malaquin D, Benali T, Boulanger J, Zemir H, Tribouilloy C. Transient impairment of coronary flow reserve in tako-tsubo cardiomyopathy is related to left ventricular systolic parameters. Eur J Echocardiogr. 2009;10:265–70.
Meimoun P, Malaquin D, Sayah S, Benali T, Luycx-Bore A, Levy F, Zemir H, Tribouilloy C. The coronary flow reserve is transiently impaired in tako-tsubo cardiomyopathy: a prospective study using serial Doppler transthoracic echocardiography. J Am Soc Echocardiogr. 2008;21:72–7.
Fujiwara S, Takeishi Y, Isoyama S, Aono G, Takizawa K, Honda H, Otomo T, Mitsuoka M, Itoh Y, Terashima M, Kubota I, Meguro T. Responsiveness to dobutamine stimulation in patients with left ventricular apical ballooning syndrome. Am J Cardiol. 2007;100:1600–3.
From AM, Prasad A, Pellikka PA, McCully RB. Are some false-positive stress echocardiograms a forme fruste variety of apical ballooning syndrome? Am J Cardiol. 2009;103:1434–8.
Mosley 2nd WJ, Manuchehry A, McEvoy C, Rigolin V. Takotsubo cardiomyopathy induced by dobutamine infusion: a new phenomenon or an old disease with a new name. Echocardiography. 2010;27:E30–3.
El Mahmoud R, Mansencal N, Pilliére R, Leyer F, Abbou N, Michaud P, Nallet O, Digne F, Lacombe P, Cattan S, Dubourg O. Prevalence and characteristics of left ventricular outflow tract obstruction in tako-tsubo syndrome. Am Heart J. 2008;156:543–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Lewis, J.F., Choi, B.G. (2013). Role of Echocardiography in Evaluation of Women with Chest Pain. In: Kaski, J., Eslick, G., Bairey Merz, C. (eds) Chest Pain with Normal Coronary Arteries. Springer, London. https://doi.org/10.1007/978-1-4471-4838-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4838-8_22
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4837-1
Online ISBN: 978-1-4471-4838-8
eBook Packages: MedicineMedicine (R0)